Novel human genes and gene expression products: II

Abstract

This invention relates to novel human genes, to proteins expressed by the genes, and to variants of the proteins. The invention also relates to diagnostic assays and therapeutic agents related to the genes and proteins, including probes, antisense constructs, and antibodies. The subject nucleic acids have been found to be differentially regulated in tumor cells, particularly in colon cancer tissue.

Description

RELATED APPLICATION INFORMATION[0001]This application is a divisional of application Ser. No. 10 / 280,403, filed on Oct. 25, 2002 which is a divisional of application Ser. No. 09 / 907,479, filed on Jul. 17, 2001, which is a continuation-in-part of application Ser. No. 09 / 385,982, filed on Aug. 30, 1999, which is a continuation-in-part of application Ser. No. 09 / 328,111, filed Jun. 8, 1999 which is based on Provisional Application Nos. 60 / 117,393, filed Jan. 27, 1999 and 60 / 098,639, filed Aug. 31, 1998, all of which are incorporated by reference herein, in their entirety.FIELD OF THE INVENTION[0002]The present invention provides nucleic acid sequences and proteins encoded thereby, as well as probes derived from the nucleic acid sequences, antibodies directed to the encoded proteins, and diagnostic methods for detecting cancerous cells, especially colon cancer cells.BACKGROUND OF THE INVENTION[0003]Colorectal carcinoma is a malignant neoplastic disease. There is a high incidence of colo...

AI Technical Summary

Benefits of technology

[0009]In another embodiment, the invention provides a transgenic animal having a transgene of a nucleic acid comprising a nucleotide sequence comprising the sequence of SEQ ID Nos. 1, 3, 5, or 7, or a sequence complementary thereto, incorporated in cells thereof. In another embodiment, the invention provides a transgenic animal having a transgene of a nucleic acid comprising a nucleic acid sequence which hybridizes under stringent conditions to a sequence comprising the sequence of SEQ ID Nos 1, 3, 5, or 7. The transgene modifies the level of expression of the nucleic acid, the stability of a mRNA transcript of the nucleic acid, or the activity of the encoded product of the nucleic acid.

Problems solved by technology

However, colorectal cancer is often detected only upon manifestation of clinical symptoms, such as pain and black tarry stool.

Generally, such symptoms are present only when the disease is well established, often after metastasis has occurred, and the prognosis for the patient is poor, even after surgical resection of the cancerous tissue.

Endoscopy is expensive, uncomfortable, inherently risky, and therefore not a practical tool for screening populations to identify those with colorectal cancer.

Non-invasive analysis of stool samples for characteristics indicative of the presence of colorectal cancer or precancer is a preferred alternative for early diagnosis, but no known diagnostic method is available which reliably achieves this goal.

Images